| Document Date: 2014-06-30 18:21:27
Open Document File Size: 637,19 KBShare Result on Facebook
City Tanox Houston / Francisco / Boston / New York / Basel / / Company Novartis / Genentech / Rodman & Renshaw / Leerink Swann & Co. / Tanox / AC Immune Ltd. / AMD / Xolair / Ciba Geigy / Caris & Co. / / Country Switzerland / United States / / Currency USD / / Event Legal Issues / FDA Phase / M&A / Business Partnership / / Facility Tanox pipeline / / IndustryTerm technology works / antibody technology / treatment of Alzheimer disease / investment bank / / MedicalCondition HIV / macular degeneration / neural disorders / pediatric asthma / age-related macular degeneration / peanut allergies / asthma / cancer / serious allergies / compound more aggresand severe allergies / cardiovascular disease / allergy / pain / neurological diseases / Alzheimer disease / peanut allergy / / Organization FDA / European Union / / Person William Tanner / Douglas Chow / Michael King / Jr. / Arthur Levinson / Mark Hollmer / / Position investment analyst / CEO / head of biotech research / analyst / / Product Lucentis / IgE / Xolair / TNX-234 / / ProvinceOrState Texas / California / / PublishedMedium NATURE BIOTECHNOLOGY / / Technology Neuroscience / antibodies / BIOTECHNOLOGY / antibody technology / / URL http /
SocialTag |
NEWS In its 30-year history, Genentech has and Novartis grew out of a settlement formed a myriad of drug developof that lawsuit in[removed]ment partnerships. But the S. San